ACBS Securities has officially revised its investment rating for Imexpharm Pharmaceutical Joint Stock Company (HoSE: IMP), downgrading the ticker from... Read more
Category: Uncategorized
Drug Administration of Vietnam penalizes two drugmakers over sub-standard bone and joint medications
The Drug Administration of Vietnam, operating under the Ministry of Health, has issued formal administrative sanctions against two pharmaceutical manufacturers... Read more
Ministry of Health mandates stringent oversight and mandatory reclamation protocols for fentanyl
The Ministry of Health has issued an urgent directive to provincial people's committees, municipal health departments, medical networks, and pharmaceutical... Read more
Muscle Strain – A Common Condition That Should Not Be Ignored
After strenuous activity, heavy lifting, sports, or prolonged poor posture, many people experience muscle pain, tightness, or stiffness. These symptoms... Read more
The Psychological Toll of Technological Integration
The emergence of mental barriers in the workplace As corporations aggressively deploy artificial intelligence to streamline operations and maximize output,... Read more
Mechanisms of Executive Advancement Within Major Enterprises
Strategic Talent Note The evolving ecosystem of healthcare, pharmaceuticals, and biotechnology demands a highly integrated leadership structure. To design high-performing... Read more
Gilead Sciences secures landmark US FDA clearance for rare and fatal liver infection
Biopharmaceutical multinational Gilead Sciences has announced that its investigational formulation targeting a rare and severe liver infection has officially secured... Read more
Gilead Sciences expands oncology portfolio via $5 billion acquisition of Tubulis
Biopharmaceutical multinational Gilead Sciences has finalized the corporate acquisition of Tubulis GmbH, a privately held, Germany-based biotech entity operating at... Read more
Moderna and Merck cancer combination demonstrates long-term efficacy in advanced melanoma
A combined therapeutic regimen engineered by Moderna and Merck & Co. has demonstrated significant long-term clinical efficacy, reducing the risk... Read more








